Ovid Therapeutics Inc (NASDAQ:OVID)

3.22
Delayed Data
As of Dec 01
 +0.245 / +8.24%
Today’s Change
1.62
Today|||52-Week Range
4.14
+73.12%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Operating ActivitiesNet Income / Starting Line-13.2M-22.4M-64.8M-52.0M
 
 
 
 
 
Depreciation11.8K56.5K80.3K141.7K
 
 
 
 
 
Total Other Cash Flow5.9M3.6M32.3M7.1M
 
 
 
 
 
Funds From Operations-7.3M-18.7M-32.5M-44.8M
 
 
 
 
 
Funds From/For Other Operating Expenses-1.8M-914.4K-996.9K787.9K
 
 
 
 
 
Net Cash Flow - Operating Activities-5.5M-17.8M-31.5M-45.6M
 
 
 
 
 
 
InvestingIncrease In Investments0.000.000.00-50.0M
 
 
Decrease In Investments0.000.000.0045.0M
 
 
Capital Expenditures-32.1K-30.4K-38.9K-33.9K
 
 
 
 
 
Net Cash Flow Investing-56.3K-189.0K-47.4K-5.4M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.00-13.7K0.000.00
 
 
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale70.6M0.0069.8M286.1K
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.00--0.00--
Other Uses - Financing0.000.003.1M0.00
 
 
Net Cash Flow - Financing70.6M-13.7K66.7M286.1K
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----------
 
Net Change In Cash65.1M-18.0M35.2M-50.6M